Big Pharma are investing huge amounts in data analytics, but what are the challenges and…
In 2018, return on investment for R&D in big pharma companies fell to just 3.7% creating a huge problem for the industry. Big pharma have there been forced to find solutions and are…
Read More...
Read More...
